SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Isotechnika
An SI Board Since August 2001
Posts SubjectMarks Bans Symbol
285 8 0 ISA
Emcee:  schzammm Type:  Unmoderated
Introduction Market Data Compact
Isotechnika is a Canadian "biotech" company that has developed an alternative to cyclosporine. This is a platform drug for multiple indications.

Please keep the topic on Isotechnika only.

I realize this is a low priced stock but their product is worth investigating. Below is their home page and a must read is the last two analyst's reports.

isotechnika.com
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
285Isotecknica (ISA.TO)off 33%. The June 28 meeting of the Dermatology and OphthalmD.Lu-6/24/2010
284<i>Last gasp?</i> Paladin Labs and Isotechnika Inc. Form Partnershitnsaf-5/8/2009
283Sorry guys.kenhott-7/22/2008
282Isotechnika says Roche gives up global rights to voclosporin for organ transplanteevee-7/21/2008
281VOCLOSPORIN COATED CORONARY STENT IMPLANTED IN FIRST PATIENT EDMONTON, Jun 11, teevee-6/11/2008
280ISOTECHNIKA PRESENTS POSITIVE DATA FROM THE PROMISE TRIAL OF VOCLOSPORIN AT THE teevee-6/4/2008
279Isotechnika selected for oral presentation at the American Transplant Congress Wtnsaf-5/29/2008
278Since I opened my big mouth re: the interim 2b PR back when... Most docs would kenhott-5/27/2008
277Isotechnika reports final results of the PROMISE trial newswire.ca EDMONTOteevee-5/27/2008
276tuck, The big driver for ISA which is not discussed in the RBC summary may be thteevee-5/13/2008
275From IHub, RBC's take on Isotechnika: siliconinvestor.com Cheers, Tucktuck-5/12/2008
274Isotechnika's Canadian Phase 3 psoriasis trial published in The Lancet ISOTEteevee-4/17/2008
273Researchers find immune drug safely treats psoriasis Thu Apr 17, 2008 6:33pm EDTteevee-4/17/2008
272ISA247: A Phase IIb Multicenter, Open Label, Concentration-Controlled Trial in Dteevee-4/16/2008
271Last patient in Isotechnika's phase 2b kidney transplant trial completes sixteevee-1/3/2008
270Isotechnika Inc. appoints two new senior company officers Wednesday October 10, tnsaf-10/10/2007
269Isotechnika's independent data monitoring committee conducts second review oteevee-8/22/2007
268Isotechnika's lead drug, ISA247, receives fast track designation from FDA foteevee-8/7/2007
267FDA allows long term use of ISA247 in Isotechnika Phase 2b kidney transplant triteevee-8/5/2007
266Health Canada allows Isotechnika to continue patients on ISA247 until commercialteevee-6/7/2007
265Isotechnika receives approval from Polish competent authority for pivotal Phase teevee-6/6/2007
264Isotechnika releases phase 2b kidney trial results 2007-05-07 06:19 ET - News Rteevee-5/7/2007
263transplant symposium coming up... isotechnika.comteevee-4/12/2007
262Isotechnika's Independent Data Monitoring Committee Conducts Review of Phaseteevee-3/28/2007
261Isotechnika receives USAN approval for generic name for lead immunosuppressive dteevee-3/12/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News